Skip to main content

Advertisement

Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy

The original article was published in Arthritis Research & Therapy 2018 20:108

Correction

Unfortunately, after publication of this article [1], it was noticed that Fig. 2 is incorrect. The correct Fig. 2 can be seen below.

Fig. 2
figure1

Prevalence rates (95% CIs) of comorbidities in cases and controls for men and women at first gout diagnosis. CI confidence interval, COPD chronic obstructive pulmonary disease, PR prevalence ratio

Reference

  1. 1.

    Drivelegka P, Sigurdardottir V, Svärd A, Jacobsson LTH, Dehlin M. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy. Arthritis Res Ther. 2018;20:108. https://doi.org/10.1186/s13075-018-1596-x

Download references

Author information

Correspondence to Panagiota Drivelegka.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark